Hiroshi Michimae

5PUBLICATIONS
27CO-AUTHORS
Cell physiologyTraditional Chinese medicine and treatmentsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 07, 2026
A Bayesian Local Gaussian-Copula Allocation Model for Bivariate Discrete-Time First-Event Data With Time-Dependent Covariates.

|Mar 27, 2025
Safety and Efficacy of Ephedrine Alkaloids-Free Ephedra Herb Extract (EFE) for Mild COVID-19: A Double-Blind, Placebo-Controlled, Randomized Comparative Trial.

Hiroshi Odaguchi, Sumiko Hyuga, Mariko Sekine

|Apr 05, 2024
A retrospective study of dose-dense paclitaxel and carboplatin plus bevacizumab as first-line treatment of advanced epithelial ovarian cancer.

Hiromi Komazaki, Kazuaki Takahashi, Hiroshi Tanabe

|May 28, 2022
Dynamic Risk Prediction via a Joint Frailty-Copula Model and IPD Meta-Analysis: Building Web Applications.

Takeshi Emura, Hirofumi Michimae, Shigeyuki Matsui

|Nov 13, 2020
Randomized phase III trial comparing pegylated liposomal doxorubicin (PLD) at 50 mg/m² versus 40 mg/m² in patients with platinum-refractory and -resistant ovarian carcinoma: the JGOG 3018 Trial.

Takashi Motohashi, Akira Yabuno, Hiroshi Michimae

Pageof 1

Frequent Collaborators

1 joint publications

Hiromi Komazaki

1 joint publications

Kazuaki Takahashi

1 joint publications

Hiroshi Tanabe

1 joint publications

Yuichi Shoburu